What is ANAB's P/E ratio?

ANAPTYSBIO INC (ANAB) currently trades at a P/E ratio of 25.21.

ANAPTYSBIO INC reports a Return on Equity (ROE) of -210.14%.

What is ANAB's dividend yield?

ANAPTYSBIO INC offers a dividend yield of 0.00%.

What is ANAB's Deepscope Quality Score?

Deepscope rates ANAB's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ANAB?

Deepscope's AI Timing Score for ANAB is 29 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ANAB belong to?

ANAPTYSBIO INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น ANAB (NASDAQ) | ANAPTYSBIO INC – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-15 | FS: 2026-03-31)

ANAB

ANAPTYSBIO INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 82

USD 59.51

3.44 (6.14%) Day Change

Watchlist Portfolio Compare Chart

25.21

P/E

0.17

D/E

-210.1%

ROE

-8.1%

ROA

0.00%

Div Yield

-1.01

PEG

ANAPTYSBIO INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 59.51 Price 3.44 (6.14%) Day Change	NEWS SCORE: 82

ANAB มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 38) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตราการเติบโตของอัตราผลตอบแทนสินทรัพย์(ROA) ปัจจุบันต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ไม่ดี , ...

ปัจจัยทางคุณภาพ

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	82
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	59.51
PBV / Sector	128.01 / 4.90
Earning Per Share	-0.98

PE / Sector	25.21 / 18.25
PEG or PE/Growth / Sector	-1.01 / 0.62
Average 1M Daily Value	27.78 M GREAT
Average 1W Daily Value	26.63 M GREAT

ปัจจัยทางเทคนิค

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-11.53 / 468.85
NPM Average (%) / Sector	-476.25 / -1,531.69
NPM Change Average (%) / Sector	-24.80 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-8.13 / 31.69
ROA Average (%) / Sector	-19.81 / -353.18
ROA Change Average (%) / Sector	22.59 / 5,214.65 GREAT
ROE (%) / Sector	-210.14 / 10.58
ROE Average (%) / Sector	-137.09 / 27.64
ROE Change Average (%) / Sector	174.20 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.61

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-16 09:59:15
Symbol	ANAB
Name	ANAPTYSBIO INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	29.10 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,631.69 / 8,995.97

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801

Phone: 858 362 6295

Website: https://www.anaptysbio.com

Employees: 104

Sector: Healthcare >> Biotechnology

Description: AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.